EPCAM deletions, Lynch syndrome, and cancer risk.

Lancet Oncol

Department of Preventive Medicine and Public Health, Creighton University, 2500 California Plaza, Omaha, NE, USA.

Published: January 2011

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70291-6DOI Listing

Publication Analysis

Top Keywords

epcam deletions
4
deletions lynch
4
lynch syndrome
4
syndrome cancer
4
cancer risk
4
epcam
1
lynch
1
syndrome
1
cancer
1
risk
1

Similar Publications

The guidelines for clinical practice for carriers of pathogenic variants in clinically relevant genes predisposing to Lynch syndrome and colorectal cancer define the steps of primary and secondary prevention that should be provided to the individuals at high risk of developing hereditary cancer in the Czech Republic. The drafting of the guidelines was organized by the Oncogenetics Working Group of the Society for Medical Genetics and Genomics of J. E.

View Article and Find Full Text PDF

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.

Oncol Rep

December 2024

Department of Biomolecular Sciences, School of Life Science, Pharmacy and Chemistry, Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston upon Thames KT1 2EE, UK.

The aberrant expression of HER family members and cancer stem cells (CSCs) have been associated with tumour progression and resistance to therapy. At present, several HER inhibitors have been approved for the treatment of patients with a range of cancers but not for the treatment of patients with hepatocellular carcinoma (HCC). The present study investigated the co‑expression and prognostic significance of HER family members, type‑III deletion mutant EGFR (EGFRvIII), and the putative CSC biomarkers CD44 and epithelial cell adhesion molecule (EpCAM) in 43 patients with HCC.

View Article and Find Full Text PDF

Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.

Diagn Pathol

October 2024

Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, 510060, China.

Article Synopsis
  • * Histological and immunohistochemical analyses revealed characteristic features of the adenocarcinoma, including specific staining patterns and a complete loss of INI-1 expression.
  • * The findings highlight the importance of understanding rare tumors like this one and encourage further research into potential therapeutic approaches for tumors deficient in SMARCB1.
View Article and Find Full Text PDF

Pressure loading regulates the stemness of liver cancer stem cells via YAP/BMF signaling axis.

J Cell Physiol

October 2024

Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400044, China.

Cancer stem cells (CSCs) are considered the major cause of the occurrence, progression, chemoresistance/radioresistance, recurrence, and metastasis of cancer. Increased interstitial fluid pressure (IFP) is a key feature of solid tumors. Our previous study showed that the distribution of liver cancer stem cells (LCSCs) correlated with the mechanical heterogeneity within liver cancer tissues.

View Article and Find Full Text PDF

Role of HNF4alpha-cMyc interaction in liver regeneration after partial hepatectomy.

Front Endocrinol (Lausanne)

August 2024

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States.

Background: Hepatocyte nuclear factor 4 alpha (HNF4α) is the master regulator of hepatic differentiation. Recent studies have also revealed the role of HNF4α in hepatocyte proliferation via negatively regulating the expression of proto-mitogenic genes, including cMyc. Here, we aimed to study the interaction between HNF4α-cMyc during liver regeneration after partial hepatectomy (PHX).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!